These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26595741)

  • 21. Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis.
    Whelan FJ; Heirali AA; Rossi L; Rabin HR; Parkins MD; Surette MG
    PLoS One; 2017; 12(3):e0172811. PubMed ID: 28253277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cystic fibrosis airway microbiome.
    Rabin HR; Surette MG
    Curr Opin Pulm Med; 2012 Nov; 18(6):622-7. PubMed ID: 22965275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aerially transmitted human fungal pathogens: what can we learn from metagenomics and comparative genomics?
    Aliouat-Denis CM; Chabé M; Delhaes L; Dei-Cas E
    Rev Iberoam Micol; 2014; 31(1):54-61. PubMed ID: 24286763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis.
    Reid DW; Latham R; Lamont IL; Camara M; Roddam LF
    J Cyst Fibros; 2013 Dec; 12(6):688-99. PubMed ID: 23706827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral-lung microbiome interactions in lung diseases.
    Mammen MJ; Scannapieco FA; Sethi S
    Periodontol 2000; 2020 Jun; 83(1):234-241. PubMed ID: 32385873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The lung microbiota. Review].
    Ploton MC; Abakka S; Amouyal E; Besnard C; Dufour L; El Harrif S; Kipnis C; Prim B; Vignot J; Houdouin V
    Arch Pediatr; 2017 Jul; 24(7):667-674. PubMed ID: 28576586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cystic fibrosis lung microbiome.
    Surette MG
    Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S61-5. PubMed ID: 24437409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients.
    Waters VJ; Stanojevic S; Sonneveld N; Klingel M; Grasemann H; Yau YC; Tullis E; Wilcox P; Freitag A; Chilvers M; Ratjen FA
    J Cyst Fibros; 2015 Nov; 14(6):755-62. PubMed ID: 25690407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nebulized colistin versus tobramycin in the treatment of chronic Pseudomonas colonization in cystic fibrosis patients].
    Quintana-Gallego E; Lopez-Campos JL; Calero C; Dapena FJ
    Med Clin (Barc); 2014 Jan; 142(2):59-63. PubMed ID: 23369499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiome in the pathogenesis of cystic fibrosis and lung transplant-related disease.
    Cribbs SK; Beck JM
    Transl Res; 2017 Jan; 179():84-96. PubMed ID: 27559681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of stability and fluctuations of cultured lower airway bacterial communities in people with cystic fibrosis.
    Sherrard LJ; Einarsson GG; Johnston E; O'Neill K; McIlreavey L; McGrath SJ; Gilpin DF; Downey DG; Reid A; McElvaney NG; Boucher RC; Muhlebach MS; Elborn JS; Tunney MM
    J Cyst Fibros; 2019 Nov; 18(6):808-816. PubMed ID: 30905581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The lung and gut microbiome: what has to be taken into consideration for cystic fibrosis?
    Héry-Arnaud G; Boutin S; Cuthbertson L; Elborn SJ; Tunney MM
    J Cyst Fibros; 2019 Jan; 18(1):13-21. PubMed ID: 30487080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosis.
    Kitsios GD; Rojas M; Kass DJ; Fitch A; Sembrat JC; Qin S; Veraldi KL; Gibson KF; Lindell K; Pilewski JM; Methe B; Li K; McDyer J; McVerry BJ; Morris A
    Thorax; 2018 May; 73(5):481-484. PubMed ID: 28802277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial.
    Aaron SD; Vandemheen KL; Ferris W; Fergusson D; Tullis E; Haase D; Berthiaume Y; Brown N; Wilcox P; Yozghatlian V; Bye P; Bell S; Chan F; Rose B; Jeanneret A; Stephenson A; Noseworthy M; Freitag A; Paterson N; Doucette S; Harbour C; Ruel M; MacDonald N
    Lancet; 2005 Aug 6-12; 366(9484):463-71. PubMed ID: 16084254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbiota: A Missing Link in The Pathogenesis of Chronic Lung Inflammatory Diseases.
    Magryś A
    Pol J Microbiol; 2021 Mar; 70(1):25-32. PubMed ID: 33815524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary Exacerbations in Children with Cystic Fibrosis.
    Waters V; Ratjen F
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S200-6. PubMed ID: 26595740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
    Rogers GB; Zain NM; Bruce KD; Burr LD; Chen AC; Rivett DW; McGuckin MA; Serisier DJ
    Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum.
    Baxter CG; Rautemaa R; Jones AM; Webb AK; Bull M; Mahenthiralingam E; Denning DW
    Thorax; 2013 Jul; 68(7):652-7. PubMed ID: 23513028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Past, Present, and Future Research on the Lung Microbiome in Inflammatory Airway Disease.
    Caverly LJ; Huang YJ; Sze MA
    Chest; 2019 Aug; 156(2):376-382. PubMed ID: 31154042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis.
    Taylor SL; Rogers GB; Chen AC; Burr LD; McGuckin MA; Serisier DJ
    Ann Am Thorac Soc; 2015 May; 12(5):701-7. PubMed ID: 25679336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.